Pending Take-Privates: Special Situations Digest Lists Penske, ADT, QIAGEN and Surgery Partners Among Deals; KKR Completes $5.7 Billion Integer Buyout

A weekly index of going-private deals, the Special Situations Digest, lists 19 take-private deals for the week to 15 November 2026, including Penske Automotive Group, ADT, QIAGEN, Surgery Partners and Accelerant Holdings. Separately, Private Equity Professional reported on 19 November that KKR completed its buyout of the medical device maker Integer Holdings at an enterprise value of about $5.7 billion.
Deals in the index
The entries below come from the part of the index Lens could read in full; the figures are the index’s, and dates are the issue dates unless the write-up gives a signing date.
- Penske Automotive Group: Penske Corporation and Mitsui, $212.00 in cash, enterprise value of $16.3 billion, agreement announced 15 October. The index gives an 8.8% premium without stating its basis.
- ADT: $10.00 in cash, a 45.6% premium to the 27 October unaffected close of $6.87, equity of about $7.6 billion and enterprise value of about $15.3 billion. The write-up names Thrive Holdings as the buyer and the header names Abode Parent, LLC.
- QIAGEN: Crown NL Bidco B.V., an EQT XI vehicle with ADIA and CPP Investments as co-investors; €46.50 (about $52) in cash by tender offer, a 40.3% premium to the 8 July unaffected price, about $12.1 billion including net debt.
- Surgery Partners: HealthSpan Partners, a Bon Secours Mercy Health affiliate, with Bain rolling about 39%; $23.50 for other holders, a 49% premium, enterprise value of about $5.7 billion.
- Accelerant Holdings: Cherry Tree BidCo, a Thoma Bravo Discover Fund V affiliate; $20.25 in cash plus a ticking fee, a 49% premium to the 12 August close of $13.61, about $5.0 billion in total funds; agreement in August.
- Intertek: EQT; £60.00 in cash plus a 107.7p dividend, roughly £9.4 billion overall; shareholders approved.
- Priority Technology: a vehicle controlled by its chairman and chief executive, Thomas Priore; $8.05 in cash, enterprise value of $1.6 billion; signed 18 September.
- MarineMax: Intrepid Holdco, a subsidiary of SHM Holdco; $53 in cash, about $1.5 billion of equity.
KKR and Integer
Private Equity Professional reports that KKR has completed its acquisition of Integer, which makes components and finished products for medical device makers and is based in Plano, Texas. It cites 2025 sales of $1.9 billion and adjusted EBITDA of $402 million, and puts the price at about 14.2 times that figure. It says the deal was funded with equity from KKR-managed funds and committed debt, with Citi, KKR Capital Markets, Barclays, UBS and Jefferies as lead arrangers, and that KKR plans an employee ownership program. KKR partner Max Lin said: “We are pleased to officially welcome Integer to the KKR portfolio.” The article gives no per-share price or separate closing date.
Where reports differ
- Penske’s buyer. The index lists Penske Corporation and Mitsui as the buyers and does not describe them as a private equity fund.
- The index itself. Its summary and verbatim text disagree on some entries, and Lens left those out, including Mobico.
Sources and notes
Lens read the Special Situations Digest going-private index, updated 15 November, and Private Equity Professional, 19 November (by John McNulty), through automated page summaries. About 64,000 of the index’s 104,000 characters were available only as a model summary, and Lens did not check any entry against its primary filing. The index predates the BILL and Global Payments news of 17 to 20 November.
Image: the trading floor of the New York Stock Exchange, used as a stand-in. Photo by Carol M. Highsmith, public domain, via Wikimedia Commons.

